Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 592, pseudogene (RN7SL592P)

Target
RN7SL592P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Processed pseudogene (arising from reverse transcription of 7SL RNA)
01

Overview

RN7SL592P represents a **processed pseudogene** related to the 7SL RNA gene family. Pseudogenes like RN7SL592P are genomic sequences that resemble functional genes but have accumulated mutations, truncations, or sequence changes that prevent them from encoding functional products. The majority of 7SL RNA-like sequences in the human genome are pseudogenes derived from the reverse transcription of 7SL RNA and reintegration into genomic DNA. RN7SL pseudogenes do not produce functional RNA and do not contribute to protein synthesis, cell signaling, or other classical biological functions. There is no evidence that RN7SL592P acts as a disease modifier, biomarker, or drug target, nor is there evidence of its expression or function in normal or pathological conditions. The parent molecule, 7SL RNA, participates critically in the signal recognition particle (SRP) ribonucleoprotein complex, which mediates co-translational protein targeting to the endoplasmic reticulum; however, RN7SL592P itself is nonfunctional and is not included in therapeutic or disease pathway considerations.

Other names
RN7SL592PRNA, 7SL, cytoplasmic 592, pseudogene
02

Mechanism of action

None (RN7SL592P is not targeted by drugs)

03

Biological functions

None (RN7SL592P is a pseudogene and is generally not expressed as functional RNA or protein)7SL RNA parent molecule functions in signal recognition particle (SRP) complex formation and protein targeting; however, RN7SL592P itself does not participate in these processes
04

Disease associations

None directly; there are no established roles for RN7SL592P in disease(The parent 7SL RNA has some implications in cancer via extracellular vesicle signaling but not specifically linked to RN7SL592P)
05

Safety considerations

None relevant; not a therapeutic target
06

Interacting drugs

None (No drugs are known to target RN7SL592P; it is not a therapeutic target)
07

Biomarkers

None (RN7SL592P is not used as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 592, pseudogene (RN7SL592P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 592, pseudogene (RN7SL592P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call